絞り込み

16642

広告

FOXC1, the new player in the cancer sandbox.

著者 Elian FA , Yan E , Walter MA
Oncotarget.2018 Jan 30 ; 9(8):8165-8178.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (5view , 0users)

Full Text Sources

In recent years, rapidly accumulating evidence implicates forkhead box C1 () in cancer, especially in studies of basal-like breast cancer (BLBC). Other studies have followed suit, demonstrating thatis not only a major player in this breast cancer subtype, but also in hepatocellular carcinoma (HCC), endometrial cancer, Hodgkin's lymphoma (HL), and non-Hodgkin's lymphoma (NHL). Thegene encodes a transcription factor that is crucial to mesodermal, neural crest, and ocular development, and mutations found inhave been found to cause dominantly inherited Axenfeld-Rieger Syndrome (ARS). Interestingly, whilemissense mutations that are associated with ARS usually reduce gene activity, increasedfunction now appears to be often linked to more aggressive cancer phenotypes in BLBC, HCC, HL, and NHL. This review discusses not only the role ofin cancer cell progression, proliferation, differentiation, and metastasis, but also the underlying mechanisms of howcan contribute to aggressive cancer phenotypes.
PMID: 29487724 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード